De Gregorio D

IRCCS San Raffaele Scientific Institute, Milan, Italy; Faculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

17 papers · ORCID

ArticlePsilocybin

Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.

Richardson B, Inserra A, Pileggi M +12

Europe PMC2025
ArticleLSD

Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT<sub>2A</sub> receptor.

Billard E, Torbey A, Inserra A +7

Europe PMC2025
ArticlePsychedelics

Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?

Pasculli G, Busan P, Jackson ES +7

Europe PMC2024
ArticlePsychedelics

The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics.

Onofrj M, Russo M, Delli Pizzi S +4

Europe PMC2023
ArticleLSD

Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.

Inserra A, Piot A, De Gregorio D +1

Europe PMC2023
ArticleLSD

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.

Inserra A, Giorgini G, Lacroix S +12

Europe PMC2023
ArticleKetamine

A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs.

Solmi M, Chen C, Daure C +14

Europe PMC2022
ArticleLSD

Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.

Inserra A, Campanale A, Cheishvili D +9

Europe PMC2022
ArticleLSD

Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.

De Gregorio D, Inserra A, Enns JP +6

Europe PMC2022
ArticlePsilocybin

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Markopoulos A, Inserra A, De Gregorio D +1

Europe PMC2021
ArticleLSD

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)

Markopoulos A, Inserra A, De Gregorio D +1

Europe PMC2021
ArticleLSD

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.

Inserra A, De Gregorio D, Rezai T +3

Europe PMC2021
ArticleLSD

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.

De Gregorio D, Popic J, Enns JP +12

Europe PMC2021
ArticlePsilocybin

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.

Inserra A, De Gregorio D, Gobbi G

Europe PMC2021
ArticlePsilocybin

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

De Gregorio D, Aguilar-Valles A, Preller KH +4

Europe PMC2021
ArticlePsilocybin

d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.

De Gregorio D, Enns JP, Nuñez NA +2

Europe PMC2018
ArticleLSD

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

De Gregorio D, Comai S, Posa L +1

Europe PMC2016